United Therapeutics UTHR
NASDAQ UTHR
$541.70 -29.68 (-5.19%)
At close: Oct 2, 2026 · 4:00 PM EDT

United Therapeutics (UTHR) Cost of Revenue (2009 - 2026)

Updated

United Therapeutics' Cost of Revenue was $99.5 million in Q2 2026, up 13.6% from $87.6 million a year earlier but down 25.4% from the prior quarter.

Analysis

United Therapeutics (UTHR) Cost of Revenue (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, United Therapeutics' Cost of Revenue was $437.2 million through Jun 30, 2026, up 28.9% year-over-year; for FY2025, it came in at $384.4 million, up 24.1% from FY2024.

  • Cost of Revenue has now increased for five consecutive years, with a five-year compound annual growth rate of 28.9% (FY2020 to FY2025).
  • In earlier years, Cost of Revenue was $309.7 million in FY2024 (+20.3%), $257.5 million in FY2023 (+69.9%), $151.6 million in FY2022 (+23.8%) and $122.5 million in FY2021 (+13.3%).
  • Quarterly Cost of Revenue has moved between $25.9 million (Q1 2022) and $133.4 million (Q1 2026) over five years.
  • Compared with a year earlier, Cost of Revenue has increased for 16 straight quarters, with growth averaging 22.5% over the last eight quarters.
  • The best year-over-year quarter for Cost of Revenue over five years was Q2 2023 (growth of 115.8%); the worst was Q2 2022 (a decline of 20.2%).
  • Per Business Quant data, UTHR's Cost of Revenue in the three quarters before Q2 2026 was $133.4 million (Q1 2026), $103.4 million (Q4 2025) and $100.9 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 United Therapeutics 23.12 Bn 12.61 Bn 683.80 Mn 99.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 99.50 Mn
Mar 31, 2026 133.40 Mn
Dec 31, 2025 103.40 Mn
Sep 30, 2025 100.90 Mn
Jun 30, 2025 87.60 Mn
Mar 31, 2025 92.50 Mn
Dec 31, 2024 75.90 Mn
Sep 30, 2024 83.10 Mn
Jun 30, 2024 77.80 Mn
Mar 31, 2024 72.90 Mn
Dec 31, 2023 71.00 Mn
Sep 30, 2023 70.10 Mn
Jun 30, 2023 64.10 Mn
Mar 31, 2023 52.30 Mn
Dec 31, 2022 58.80 Mn
Sep 30, 2022 37.20 Mn
Jun 30, 2022 29.70 Mn
Mar 31, 2022 25.90 Mn
Dec 31, 2021 34.60 Mn
Sep 30, 2021 27.70 Mn
API Access

United Therapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=UTHR&period=max&api_key=YOUR_API_KEY